Search Results - "Joetham, A"

Refine Results
  1. 1

    Dysregulation of metabolic pathways in a mouse model of allergic asthma by Quinn, K. D., Schedel, M., Nkrumah‐Elie, Y., Joetham, A., Armstrong, M., Cruickshank‐Quinn, C., Reisdorph, R., Gelfand, E. W., Reisdorph, N.

    Published in Allergy (Copenhagen) (01-09-2017)
    “…Background Asthma is a complex lung disease resulting from the interplay of genetic and environmental factors. To understand the molecular changes that occur…”
    Get full text
    Journal Article
  2. 2

    Development of eosinophilic airway inflammation and airway hyperresponsiveness in mast cell-deficient mice by Takeda, K, Hamelmann, E, Joetham, A, Shultz, L D, Larsen, G L, Irvin, C G, Gelfand, E W

    Published in The Journal of experimental medicine (04-08-1997)
    “…Mast cells are the main effector cells of immediate hypersensitivity and anaphylaxis. Their role in the development of allergen-induced airway…”
    Get full text
    Journal Article
  3. 3

    IL-10 Is Necessary for the Expression of Airway Hyperresponsiveness but Not Pulmonary Inflammation after Allergic Sensitization by Makela, M. J., Kanehiro, A., Borish, L., Dakhama, A., Loader, J., Joetham, A., Xing, Z., Jordana, M., Larsen, G. L., Gelfand, E. W.

    “…Cytokines play an important role in modulating inflammatory responses and, as a result, airway tone. IL-10 is a regulatory cytokine that has been suggested for…”
    Get full text
    Journal Article
  4. 4

    Effects of combination therapy with montelukast and carbocysteine in allergen‐induced airway hyperresponsiveness and airway inflammation by Takeda, K, Shiraishi, Y, Matsubara, S, Miyahara, N, Matsuda, H, Okamoto, M, Joetham, A, Gelfand, EW

    Published in British journal of pharmacology (01-07-2010)
    “…Background and purpose:  Montelukast and S‐carbocysteine have been used in asthmatic patients as an anti‐inflammatory or mucolytic agent respectively…”
    Get full text
    Journal Article
  5. 5
  6. 6

    A Murine IL-4 Receptor Antagonist That Inhibits IL-4- and IL-13-Induced Responses Prevents Antigen-Induced Airway Eosinophilia and Airway Hyperresponsiveness by Tomkinson, A, Duez, C, Cieslewicz, G, Pratt, J. C, Joetham, A, Shanafelt, M.-C, Gundel, R, Gelfand, E. W

    Published in The Journal of immunology (1950) (01-05-2001)
    “…The closely related Th2 cytokines, IL-4 and IL-13, share many biological functions that are considered important in the development of allergic airway…”
    Get full text
    Journal Article
  7. 7

    Anti-interleukin 5 but not anti-ige prevents airway inflammation and airway hyperresponsiveness by HAMELMANN, E, CIESLEWICZ, G, SCHWARZE, J, ISHIZUKA, T, JOETHAM, A, HEUSSER, C, GELFAND, E. W

    “…The role of IL-5 and allergen-specific IgE in the development of eosinophilic airway inflammation and airway hyperresponsiveness (AHR) was investigated in a…”
    Get full text
    Journal Article
  8. 8

    Role of CD8+ Effector Memory T Cell-Derived IL-6 in the Development of Airway Hyperresponsiveness and Inflammation by Jia, Y, Takeda, K, Han, J, Joetham, A, Lucas, J.J, Gelfand, E.W

    Published in Journal of allergy and clinical immunology (01-02-2011)
    “…CD8+ effector memory T cells (Teff) restore airway hyperresponsiveness (AHR) and inflammation in CD8-deficient (CD8-/-) mice (Nat Med 2004:865), and was…”
    Get full text
    Journal Article
  9. 9
  10. 10

    Jagged1, a Ligand for Notch Receptor Expressed on Dendritic Cells, Regulates Airway Hyperresponsiveness and Inflammation by Initiating Th2 Responses by Okamoto, M, Takeda, K, Matsuda, H, Joetham, A, Domenico, J, Lucas, J.J, Gelfand, E.W

    Published in Journal of allergy and clinical immunology (01-02-2009)
    “…Bone marrow-derived dendritic cells (BMDC) were cultured with purified LPS-free ovalbumin (OVA) with/without added LPS and analyzed for Notch ligand expression…”
    Get full text
    Journal Article
  11. 11

    Importance of Both Allergen-Specific (ANR) and Non-Specific Nasal Reactivity (NNR) in the Development of Early- and Late-Phase Nasal Responses by Miyahara, S, Miyahara, N, Matsubara, S, Joetham, A, Gelfand, E.W

    “…Allergen-specific (ANR) and allergen non-specific (NNR) nasal responses have been investigated separately, and it remains unclear how the NNR component…”
    Get full text
    Journal Article
  12. 12

    Treatment of RSV-Infected Newborn Mice With Anti-IgE Antibody Attenuates the Subsequent Enhancement of Airway Hyperresponsiveness on Re-Infection by Dakhama, A, Lee, Y, Balhorn, A, Joetham, A, Gelfand, E.W

    “…RSV-specific IgE antibodies enhance airway hyperresponsiveness (AHR) in mice (AJRCCM 2004, 170:952) and neonatal RSV infection predisposes to the development…”
    Get full text
    Journal Article
  13. 13

    Fexofenadine reverses established allergen-induced airway disease by Joetham, A., Takeda, K., Gelfand, E.W.

    Published in Journal of allergy and clinical immunology (01-02-2005)
    “…The aim of this study was to determine the efficacy of fexofenadine in reversing established airway hyperresponsiveness and in normalizing ongoing…”
    Get full text
    Journal Article
  14. 14

    Reduction of allergic airway responses in P-selectin-deficient mice by De Sanctis, George T, Wolyniec, Walter W, Green, Francis H. Y, Qin, Shixin, Jiao, Aiping, Finn, Patricia W, Noonan, Thomas, Joetham, Anthony A, Gelfand, Erwin, Doerschuk, Claire M, Drazen, Jeffrey M

    Published in Journal of applied physiology (1985) (01-09-1997)
    “…George T. De Sanctis 1 , Walter W. Wolyniec 2 , Francis H. Y. Green 3 , Shixin Qin 4 , Aiping Jiao 1 , Patricia W. Finn 1 , Thomas Noonan 2 , Anthony A…”
    Get full text
    Journal Article
  15. 15

    The Role of Notch in Effector Memory CD8+ T Cell Development of Airway Hyperresponsiveness by Okamoto, M, Takeda, K, Joetham, A, Ohnishi, H, Matsuda, H, Swasey, C.H, Dakhama, A, Gelfand, E.W

    Published in Journal of allergy and clinical immunology (01-02-2008)
    “…Results Both C57Bl/6 and CD8-/- mice, recipients of GSI-treated TEFF, developed lower levels of AHR and reduced numbers of eosinophils and IL-13, accompanied…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Combination of Interleukin (IL)-2 and IL-18 Attenuates Allergen-Induced Airway Hyperresponsiveness (AHR) and Inflammation through An IL-12-STAT4-Interferon (IFN)-gamma Pathway by Matsubara, S., Takeda, K., Kodama, T., Koya, T., Miyahara, N., Joetham, A., Swasey, C.H., Dakhama, A., Gelfand, E.W.

    Published in Journal of allergy and clinical immunology (01-02-2006)
    “…C57BL/6, IFN-gamma-deficient and signal transducer and activator of transcription (STAT)4-deficient mice were sensitized to ovalbumin (OVA) and challenged with…”
    Get full text
    Journal Article
  18. 18

    Role of Endogenous Estrogen in Regulating Airway Hyperresponsiveness Induced by Allergen Inhalation Without Adjuvant by Matsubara, S, Swasey, C.H, Dakhama, A, Loader, J.E, Ohnishi, H, Joetham, A, Balhorn, A, Miyahara, N, Takeda, K, Gelfand, E.W

    “…OVA-exposed male mice showed significant (p<0.01) increases in airway responsiveness to inhaled MCh, but AHR could not be detected in female mice…”
    Get full text
    Journal Article
  19. 19

    In Vitro and in Vivo Effects of IL-10-Treated Dendritic Cells on Airway Allergic Inflammation by Koya, T., Takeda, K., Matsubara, S., Miyahara, N., Miyahara, S., Swasey, C., Barhorn, A., Joetham, A., Dakhama, A., Gelfand, E.W.

    Published in Journal of allergy and clinical immunology (01-02-2006)
    “…Myeloid DCs (mDCs) were generated from bone marrow cells of C57BL/6 mice co-cultured with GM-CSF and IL-4 in the presence (IL-10+mDCs) or absence (IL-10-mDC)…”
    Get full text
    Journal Article
  20. 20

    STAT4 deficiency exaggerates airway hyperresponsiveness (AHR) after repeated ovalbumin (OVA) challenge by Matsubara, S., Kodama, T., Takeda, K., Miyahara, N., Joetham, A., Taube, C., Dakhama, A., Park, J., Koya, T., Gelfand, E.W.

    Published in Journal of allergy and clinical immunology (01-02-2005)
    “…STAT4-deficient mice and their congenic littermates were sensitized to OVA by intraperitoneal injection (twice) and subsequently challenged (via the airways)…”
    Get full text
    Journal Article